Prevent Cancer Foundation Blog

Early Detection

Keep calm and check ’em

Posted by Jessica Karlsruher, Development Director, Testicular Cancer Foundation on December 18th, 2014 | No Comments »
Jessica Karlsruher

We hear so much in the marketplace about breast cancer, but very little about testicular cancer. Testicular cancer is the most common cancer in males ages 15-35, and it is 99 percent treatable if caught in its early stages. But just as most men procrastinate about their health, I originally procrastinated writing this blog post. As the Development Director at the Testicular Foundation (TCF), I started to think, “How do I do my job? What makes ...

Stomp cervical cancer out of your life!

Posted by Lisa McGovern, Executive Director, Congressional Families Program on January 17th, 2014 | No Comments »

At my eleven-year-old daughter’s annual checkup, our doctor talked to us about getting the vaccine that prevents cervical cancer. We also discussed the need for my fourteen-year--old son to get one. I had a lot of questions, both as a mother and as a woman. January is Cervical Health Awareness Month -- the perfect time to ask those questions, learn more and get answers. Cervical cancer is a silent killer. Human papillomavirus virus or HPV is ...

USPSTF issues draft recommendations for CT lung cancer screening

Posted by Prevent Cancer Foundation Staff on August 6th, 2013 | No Comments »
avatar

The U.S. Preventive Services Task Force (USPSTF) issued draft recommendations for annual low-dose CT lung cancer screening for adults ages 55 to 79 who have quit smoking in the last 15 years or who have a 30 pack-year history of smoking. The draft recommendations received a grade B. There will be a public comment period before the final recommendation is issued. The Affordable Care Act (ACA) requires insurers to cover screening tests graded a B or ...

Doctors and patients not communicating about PSA test

Posted by Prevent Cancer Foundation Staff on August 5th, 2013 | No Comments »
avatar

According to two studies and a survey, doctors and patients are not participating in a process called shared decision-making regarding the prostate-specific antigen (PSA) test. Shared decision-making is the process by which doctors and patients have a discussion about the advantages and disadvantages of the PSA test and the patient shares his concerns and health issues. The doctor then reviews the options with the patient and together they would decide on personalized options regarding prostate ...